Who Should and Shouldn't Consider GLP-1 Therapy: Mental Health Screening GLP-1 medications are not psychiatrically indicated treatments for anxiety or depression
Rare but serious side effects While rare, GLP-1 Meds have been associated with more severe gastrointestinal issues, including: Pancreatitis: Inflammation of the pancreas characterized by abdominal pain, nausea and vomiting
Some protocols recommend waiting longer, up to 2 weeks, particularly for patients transitioning from high tirzepatide doses (12.5 mg or 15 mg) to reduce the overlap of active drug and minimize initial side effects
FIGURE 14 The available structural data on the GLP-1GLP-1R system reveal that GLP-1 occupies the deep transmembrane pocket of the GLP-1R and establishes several intermolecular interactions with crucial residues on the N-terminus, ECL2, TM1, TM2, TM5, TM6, and TM7 of GLP-1R (Figure 14), which are also sustained over the duration of MD simulations
What other conditions cause lip